- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Vericel Corp Ord (VCEL)
Vericel Corp Ord stock price live, this page displays NASDAQ VCEL stock exchange data. View the VCEL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Vericel Corp Ord real time stock price chart below.
What Is the Vericel Corp Ord Stock Price Today?
The Vericel Corp Ord stock price today is 34.94.
What Is the Stock Symbol for Vericel Corp Ord?
The stock symbol for Vericel Corp Ord is ""VCEL.""
What Stock Exchange Does Vericel Corp Ord Trade On?
Vericel Corp Ord is listed and trades on the NASDAQ stock exchange.
Is Vericel Corp Ord a Good Stock to Buy?
Determining whether Vericel Corp Ord—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VCEL quote. (ISIN: US92346J1088)
What Is the Vericel Corp Ord Stock Price Today?
The Vericel Corp Ord stock price today is 34.94.
What Is the Stock Symbol for Vericel Corp Ord?
The stock symbol for Vericel Corp Ord is ""VCEL.""
What Stock Exchange Does Vericel Corp Ord Trade On?
Vericel Corp Ord is listed and trades on the NASDAQ stock exchange.
Is Vericel Corp Ord a Good Stock to Buy?
Determining whether Vericel Corp Ord—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VCEL quote. (ISIN: US92346J1088)
34.94
-5.72(-14.07%)
Closed·
After Hours
34.88-0.06(-0.17%)
·
Fair Value
An estimate of a Vericel Corp Ord's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
34.92
38.27
52 wk Range
34.87
63.00
VCEL Scorecard
Full Analysis
3 analysts have revised their earnings downwards for the upcoming period
Earnings results expected today
More Info
Fair Value
An estimate of a Vericel Corp Ord's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
34.9238.27
52 wk Range
34.8763.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
VCEL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Vericel Corp Ord's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
58.13
Upside
+66.36%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Vericel Corp Ord Company Profile
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
Vericel Corp Ord SWOT Analysis
MACI Arthro Triumph | Vericel's FDA approval for MACI Arthro expands its cartilage repair market, positioning it as the only arthroscopic biologic solution for knee defects up to 4cm2 |
Market Expansion Strategy | Delve into Vericel's plan to grow its surgeon base from 5,000 to 7,000, targeting high-volume arthroscopic specialists to drive MACI Arthro adoption |
Revenue Potential | Explore how MACI Arthro could significantly boost Vericel's revenues by penetrating the 2-4cm² condyle defect market, potentially doubling total MACI sales |
Competitive Edge | Learn about Vericel's strengthened position in the $3 billion cartilage repair market, with analysts setting a price target of $57.00 for August 2024 |
Vericel Corp Ord Earnings Call Summary for Q2/2025
- Q2 net loss narrowed to $0.01 per share, beating forecasts; revenue up 20% YoY to $63.2M but missed expectations
- Gross margin improved to 74%; company maintains strong cash position of $164M with no debt
- Full-year MACI revenue growth guidance in low 20% range; plans to expand sales force and prepare new manufacturing facility
- Stock fell 6.9% pre-market despite EPS beat, reflecting investor concerns over revenue miss
- Management confident in growth trajectory, emphasizing sustained high revenue and profitability growth potential
Last Updated: 31/07/2025, 16:56
Read Full TranscriptCompare VCEL to Peers and Sector
Metrics to compare | VCEL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVCELPeersSector | |
|---|---|---|---|---|
P/E Ratio | 687.4x | −3.3x | −0.5x | |
PEG Ratio | 1.32 | 0.03 | 0.00 | |
Price/Book | 6.9x | 5.2x | 2.6x | |
Price / LTM Sales | 8.6x | 5.8x | 3.3x | |
Upside (Analyst Target) | 43.9% | 65.8% | 42.4% | |
Fair Value Upside | Unlock | 26.3% | 7.2% | Unlock |
Analyst Ratings
8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 58.13
(+66.36% Upside)
Earnings
Latest Release
Jul 31, 2025
EPS / Forecast
-0.01 / -0.03
Revenue / Forecast
63.24M / 64.61M
People Also Watch
FAQ
What Stock Exchange Does Vericel Corp Ord Trade On?
Vericel Corp Ord is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Vericel Corp Ord?
The stock symbol for Vericel Corp Ord is "VCEL."
What Is the Vericel Corp Ord Market Cap?
As of today, Vericel Corp Ord market cap is 1.77B.
What Is Vericel Corp Ord's Earnings Per Share (TTM)?
The Vericel Corp Ord EPS (TTM) is 0.06.
When Is the Next Vericel Corp Ord Earnings Date?
Vericel Corp Ord will release its next earnings report on 30 Jul 2025.
From a Technical Analysis Perspective, Is VCEL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Vericel Corp Ord Stock Split?
Vericel Corp Ord has split 2 times.
How Many Employees Does Vericel Corp Ord Have?
Vericel Corp Ord has 357 employees.
What is the current trading status of Vericel Corp Ord (VCEL)?
As of 31 Jul 2025, Vericel Corp Ord (VCEL) is trading at a price of 34.94, with a previous close of 40.66. The stock has fluctuated within a day range of 34.92 to 38.27, while its 52-week range spans from 34.87 to 63.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.